AZTR - Azitra, Inc.
IEX Last Trade
0.4041
-0.005 -1.163%
Share volume: 600
Last Updated: Thu 26 Dec 2024 08:22:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.41
0.00
-1.15%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.81%
1 Month
-17.53%
3 Months
-26.65%
6 Months
-88.38%
1 Year
-98.99%
2 Year
-99.72%
Key data
Stock price
$0.40
DAY RANGE
$0.40 - $0.41
52 WEEK RANGE
$0.30 - $68.40
52 WEEK CHANGE
-$98.72
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Francisco D. Salva
Region: US
Website: azitrainc.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: azitrainc.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
We are an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. We were incorporated under the laws of the state of Delaware on January 2, 2014. Our principal executive offices are located at 21 Business Park Drive, Branford, Connecticut.
Recent news